OneMedPlace's Med Tech Sentinel Features Tearlab Corporation

March 30, 2009 - PRLog -- The Med Tech Sentinel http://www.onemedplace.com/blog/ covers the latest in medical technology innovation and investment opportunity, with emphasis on emerging companies. It is the first blog located at OneMedPlace, a virtual community of entrepreneurs, investors, physicians, and other constituents of the healthcare and life sciences fields. OneMedPlace is the creation of its namesake, a New York-based communications firm dedicated to bringing efficiency to the chaos of company development.

This week's video profile covers Tearlab Corporation, who is developing a point-of-care diagnostic test that uses tears to identify disease-indicating protein biomarkers.

About Tearlab Corporation:

TearLab Corporation is an in-vitro diagnostics company developing and commercializing novel, lab-on-a-chip technologies that enable eye care practitioners to test for highly sensitive and specific biomarkers in tears at the point-of-care. For additional information on Tearlab Corporation, please visit http://www.onemedplace.com/database/list/cid/2131/.

About OneMedPlace: OneMedPlace http://www.onemedplace.com is a virtual community of health care and life science companies. It has, for the first time, put in place the innovations that will shape the future of health and medicine—emerging companies and technologies seeking capital, distribution, visibility and resources to help finance, build and grow, and investors and strategic partners looking for health and medical innovations to invest in, acquire, license, distribute, purchase or utilize.

# # #

OneMedPlace is a communications platform for healthcare and life sciences companies to connect with investors, strategic partners, and customers.